DANIEL OEHLER: Open Payments
NPI 1801921101 · SURFSIDE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 21 payments from 8 companies in 2025. Trend: 2023 $324 · 2024 $412 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $196 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $66 |
| Optinose US, Inc. | 3 | $57 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Stryker Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: DUPIXENT, NUCALA, NEFFY, Xhance, LATERA, TEZSPIRE, INSPIRE.
Industry payments across SC — which companies pay providers there.
